Melanoma Focus Virtual Regional Meeting 2021
We are delighted to announce that registration is now open for this year’s Melanoma Focus Virtual Regional Meeting. The event is organised by Dr. Matthew Wheater, Consultant Medical Oncologist, University Hospital Southampton NHS Foundation Trust.
Member Registration
Non-Member Registration
2021 Registration Fees:
Register before 16th April 2021 for early bird rates.
| Member | Early Bird | Late Registration | |
| Consultant | £79 | ||
| Other Clinician | £49 | £59 | |
| Nurse / AHP / Retired | £25 | £35 | |
| Non-Member | |||
| Consultant/Industry | £119 | ||
| Other Clinician | £75 | ||
| Nurse / AHP / Retired | £45 | £55 | |
| Industry | £149 | £149 |
2021 Draft Programme:
| 09:00 – 09:15 | Welcome & Melanoma Focus Business Meeting Mark Harries, Chairman Melanoma Focus/Susanna Daniels |
| 09:15 – 12:15 | Pharma Exhibition Area |
| 09:20 – 10:00 | Meet the Expert (Professor Christian Ottensmeier) RNA vaccines and IO |
| 10:10 – 10:50 | Virtual Networking x 4 concurrent (Surgeons/Dermatologists/Oncologists/CNS) |
| 11:00 – 12:00 | Novartis Sponsored Symposium |
| 12:20 – 12:25 | Welcome Dr Matthew Wheater (Organiser), Consultant Medical Oncologist, University Hospital Southampton NHS Foundation Trust |
| 12:25 – 14:00 | Session 1: Immunotherapy Toxicity |
| 12:25 – 12:30 | Session 1: Immunotherapy Toxicity Chair: tbc |
| 12:30 – 12:55 | Immunotherapy toxicity – a patient’s story Helen Moorey, Lead Skin Cancer CNS, University Hospital Southampton Ian Goddard, Melanoma Patient |
| 12:55 – 13:20 | Managing immunotherapy toxicity – the Clatterbridge experience Dr Anna Olsson-Brown, MRC Clinical Research Fellow, Clatterbridge Cancer Centre |
| 13:20 – 13:45 | Recognising and managing skin toxicity from checkpoint inhibitors Dr Louise Fearfield, Consultant Dermatologist, Royal Marsden Hospital |
| 13:45 – 14:00 | Q & A |
| 14:00 – 14:10 | Comfort Break |
| 14:10 – 15:50 | Session 2: Future Directions of Immunotherapy and Mechanisms of Resistance |
| 14:10 – 14:15 | The future of immunotherapy – checkpoint inhibitors and beyond Professor Christian Ottensmeier, Professor of Immuno-Oncology, Liverpool Head and Neck Centre & Clatterbridge Cancer Centre NHS Foundation Trust |
| 14:55 – 15:40 | PD1 Inhibition – a double-edged sword? Hyperprogression and resistance to immunotherapy Dr Simon Eschweiler, La Jolla Institute for Immunology, California |
| 15:40 – 16:00 | Comfort Break |
| 16:10 – 16:50 | Session 3: Advanced Ocular Melanoma – case driven discussion Chair: Dr Ioannis Karydis, Consultant Medical Oncologist, University Hospital Southampton Mr Arjun Takhar, Consultant Hepatobiliary Surgeon, University Hospital Southampton Dr Sachin Modi, Consultant Interventional Radiologist, University Hospital Southampton Dr Paul Nathan, Consultant Medical Oncologist, Mt Vernon Cancer Centre |
| 16:55 – 17:40 | Session 4: Locally-Advanced Disease – MDT Chair and speakers tbc |
| 17:40 – 17:45 | Concluding Remarks and Close Dr Matthew Wheater |
